GGrantIndex
Sort

51,593 grants matching hepatitis

Central Mechanisms Regulating Energy Homeostasis, Project 2 of 10

$770,085
Joel K Elmquist · Ut Southwestern Medical Center · RL1 · FY2008 · DK

Small molecule targeting viral nucleotidyltransferases

$770,031
Stuart F. J. Le Grice · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Expanding Ohio's Testing Capability and Capacity to Support a National Integrated Food Safety System

$770,000
Jason Siu Kong · Ohio State Department Of Agriculture · U19 · FY2025 · FD

PDGFR and KDR Inhibitors for Liver Fibrosis

$769,978
Prakash Narayan · Angion Biomedica Corporation · R44 · FY2014 · DK

Mechanisms of Chronic Hepatitis B Infection and Therapeutic Vaccines

$769,814
David R. Milich · Vaccine Research Institute Of San Diego · R01 · FY2009 · AI

Profiling the protective B cell response to HCV

$769,796
Steven Foung · Stanford University · U19 · FY2018 · AI

The Impact of HCV Treatment in HIV/HCV coinfected and HCV monoinfected Incarcerated Persons on HCV Elimination

$769,782
Risha Irvin · Johns Hopkins University · R01 · FY2022 · DA

Physiologic Consequence of Genetic Variation

$769,738
Richard M Watanabe · University Of Southern California · R01 · FY2019 · DK

Physiologic Consequence of Genetic Variation

$769,738
Richard M Watanabe · University Of Southern California · R01 · FY2018 · DK

Effects of GLP-l receptor agonists on cardiometabolic alterations in HIV-associated lipohypertrophy

$769,710
Grace A McComsey · Case Western Reserve University · R01 · FY2020 · DK

Expanding Medication Assisted Therapy in Ukraine (ExMAT)

$769,707
Frederick Lewis Altice · Yale University · R01 · FY2017 · DA

The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network

$769,433
Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2016 · DA

Deciphering the ontogeny of CD4+ resident memory T cells that globally seed the skin and protect against cutaneous leishmaniasis

$769,366
Phillip A. Scott · University Of Pennsylvania · R01 · FY2025 · AI

Human Genetic determinants of HBV recovery

$769,106
David L Thomas · Johns Hopkins University · R01 · FY2025 · AI

Antisense Mediated Treatment of Hepatitis B Virus Infection

$768,816
Urtzi Garaigorta · Scripps Research Institute, The · R01 · FY2015 · AI

Technology Core - The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN)

$768,805
Sally M McFall · Northwestern University · U54 · FY2023 · EB

HIV and Hepatitis C Pathogenesis & The Human Genome

$768,803
David L Thomas · Johns Hopkins University · R01 · FY2014 · DA

Seq-Scope: Microscopic Examination of Spatial Single Cell Transcriptome in Cell and Tissue Senescence

$768,615
Jun Hee Lee · University Of Michigan At Ann Arbor · UH3 · FY2023 · CA

Assessing the impact of acquired immunodeficiency on congenital Zika virus

$768,565
David H Oconnor · University Of Wisconsin-Madison · R01 · FY2018 · AI

DEVELOPING MULTI-ANTIGEN VACCINE FOR THE TREATMENT OF CHRONIC HBV

$768,496
Valerian Nakaar · Carogen Corporation · R44 · FY2020 · DK

Pathogenesis of youth onset pre-diabetes and Type 2 diabetes

$768,468
Sonia Caprio · Yale University · R01 · FY2021 · DK

Project 1: Perturbation of Pre-Existing Immunity to Chronic Viral Infection Through Immunotherapy

$768,384
Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2022 · AI

Immunologic and Fat-Associated Predictors of Insulin Resistance in Treated HIV

$768,378
Suneil Krishna Koliwad · University Of California, San Francisco · R01 · FY2019 · DK

Antisense Mediated Treatment of Hepatitis B Virus Infection

$768,305
Stefan Frank Wieland · Scripps Research Institute, The · R01 · FY2012 · AI

Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes

$768,280
Gabriel Quantum Shaibi · Arizona State University-Tempe Campus · U01 · FY2024 · DK